Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NONA-LISA: Non-pharmacological vs Fentanyl for LISA
NCT05609877Recruiting
- Sponsor
- Rigshospitalet
- Start
- Jun 2024
- Primary completion
- May 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of fentanyl in respiratory distress syndrome (RDS) (2 arms), sponsored by Rigshospitalet. Primary endpoint: LISA failure defined as need for invasive ventilation. Started Jun 2024; status: recruiting.
02
Drugs
fentanyl
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on NCT05609877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05609877.